Imaging of nodal metastases in the head and neck

Journal of Magnetic Resonance Imaging

Volumn 7, Issue 5, 1997, Pages 774-783

  Anzai, Yoshimi ^a   Brunberg, James A ^a   Lufkin, Robert B ^b  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Head and neck neoplasm; Iron oxide; Lymphatic system; Magnetic resonance imaging; Nodal metastasis; Positron emission tomography

Indexed keywords

ARTICLE; CANCER LOCALIZATION; CANCER STAGING; CLINICAL PROTOCOL; DIAGNOSTIC IMAGING; HEAD AND NECK CANCER; HUMAN; LYMPH NODE METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ADULT; AGED; BIOPSY, NEEDLE; CARCINOMA, SQUAMOUS CELL; CONTRAST MEDIA; DIAGNOSTIC IMAGING; FEMALE; FERRIC COMPOUNDS; HEAD AND NECK NEOPLASMS; HUMANS; IMAGE ENHANCEMENT; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NECK; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0031403808     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.1880070503     Document Type: Article

References (69)

1. Batsakis JG. Squamous cell carcinoma of the oral cavity and the oropharynx. In: Tumors of the head and neck. Clinical and pathological considerations, 2nd ed. Baltimore: Williams & Wilkins, 1979; 240-250.
2. Lindberg R. Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 1972; 29:1446-1449.
3. Bocca E, Calearo C, de Vincentiis I, Marullo T, Motta G, Ottaviani A. Occult metastases in cancer of the larynx and their relationship to clinical and histological aspects of the primary tumor: a four year multicentric research. Laryngoscope 1984; 94:1086-1090.
4. Friedman M, Roberts N, Kirshenbaum G, Colombo J. Nodal size of metastatic squamous cell carcinoma of the neck. Laryngoscope 1993; 103:854-856.
5. Johnson JT. A surgeon looks at cervical lymph nodes. Radiology 1990; 177:607-610.
6. Rouviere H. Lymphatic system of the head and neck. In: Anatomy of the human lymphatics system, Tobias MJ, translator. Ann Arbor, MI: Edward Brothers, 1938; 5-28.
7. Spiessel B, Beahrs OH, Hermanek P, et al. Head and neck tumors. In: TNM atlas. Illustrated guide to the TNM/pTNM-classification of malignant tumor, 3rd ed. Berlin: Springer-Verlag, 1989; 3-56.
8. Robbins TK, Medina JE, Wolfe GT, Levine PA, Sessions RB, Pruet CW. Standardizing neck dissection terminology. Arch Otolaryngol Head Neck Surg 1991; 117:601-605.
9. Mancuso AA, Hamsberger HR, Muraki AS, Stevens MH. Computed tomography of cervical and retropharyngeal lymph nodes: normal anatomy, variants of normal and applications in staging head and neck cancer. Part I: normal anatomy. Radiology 1983; 148:709-714.
10. Som PM. Lymph nodes of the neck. Radiology 1987; 165: 593-600.
11. Som PM. Detection of metastasis in cervical lymph nodes: CT and MR criteria and differential diagnosis. Am J Roentgenol 1992; 158:961-969.
12. Mancuso AA, Maceri D, Rice D, Hanafee WN. CT of cervical lymph node cancer. Am J Roentgenol 1981, 136:381-385.
13. Mancuso AA, Hamsberger HR, Muraki AS, Stevens MH. Computed tomography of cervical and retropharyngeal lymph nodes: normal anatomy, variants of normal, and applications in staging of head and neck cancer. Part II. Pathology. Radiology 1983; 148:715-723.
14. van den Brekel MWM, Stel HV, Castelijins JA, et al. Cervical lymph node metastases: assessing of radiological criteria. Radiology 1990; 177:379-384.
15. Don D, Anzai Y, Lufkin RB, Fu YS, Calcaterra T, Lufkin R. Evaluation of cervical lymph node metastases in squamous cell carcinoma of the head and neck. Laryngoscope 1995; 105: 669-674.
16. van den Brekel MWM, Castelijins JA, Stel HV, et al. Detection and characterization of metastatic cervical adenopathy by MR imaging: comparison of different MR techniques. J Comput Assist Tomogr 1990; 14:581-589.
17. Snyderman NL, Johnson JT, Schramm VL, Meyers EN, Bedetti CD, Thearle P. Extracapsular spread of carcinoma in cervical lymph nodes. Cancer 1985; 56:1597-1599.
18. Jinkins JR. Computed tomography of the craniocervical lymphatic system: anatomical and functional considerations. Neuroradiology 1987; 29:317-326.
19. Steinkamp HJ, Hosten N, Richter C, Schedel H, Felix R. Enlarged cervical lymph nodes at helical CT. Radiology 1994; 191:795-798.
20. Dooms GC, Hricak H, Crooks LE, et al. Magnetic resonance imaging of the lymph nodes. Comparison with CT. Radiology 1984; 153:719-728.
21. Dooms GC, Hricak H, Moseley MR, Bottles K, Fisher MR, Higgins CB. Characterization of lymphadenopathy by magnetic relaxation times: preliminary results. Radiology 1985; 155:691-697.
22. Zoarski GH, Mackey K, Anzai Y, et al. Head and neck: initial clinical experience with fast spin echo MR imaging. Radiology 1993; 188:323-327.
23. Levin JS, Curtin HD, Ross JS, Weissman JL, Obuchowski NA, Tkach JA. Fast spin-echo imaging of the neck: comparison with conventional spin-echo, utility of fat suppression, and evaluation of tissue contrast characteristics. Am J Neuroradiol 1994; 15(7):1351-1357.
24. Tien RD, Robbins KT. Correlation of clinical, pathologic, and MR fat suppression results for head and neck cancer. Head Neck 1992; 14(4):278-284.
25. Barakos JA, Dillon WP, Chew WM. Orbit, skull base, and pharynx: contrast-enhanced fat suppression MR imaging. Radiology 1991; 179:191-198.
26. Anzai Y, Lufkin RB, Jabour BA, Hanafee WN. Fat suppression failure artifacts simulating pathology on frequency selective fat suppression MR imaging in the head and neck. Am J Neuroradiol 1992; 13:879-884.
27. Yousem D, Som PM, Hackney DB, Schwaibold F, Hendrix RA. Central nodal necrosis and extracapsular neoplastic spread in cervical lymph nodes: MR imaging versus CT. Radiology 1992; 182:753-759.
28. Yousem DM, Hatabu H, Hurst RW, et al. Carotid artery invasion by head and neck masses: prediction with MR imaging. Radiology 1995; 195(3):715-720.
29. Yousem DM, Montone KT, Sheppard LM, Rao VM, Weinstein GS, Hayden RE. Head and neck neoplasms: magnetization transfer analysis. Radiology 1994; 192(3):703-707.
30. Markkola AT, Aronen HJ, Paavonen T, et al. Spin lock and magnetization transfer imaging of head and neck tumors. Radiology 1996; 200:369-375.
31. Yousem D. MT imaging of cervical nodal metastases (abstract). American Society of Neuroradiology, Nashville, 1994.
32. van den Brekel MW, Stel HV, Castelijins JA, Croll GJ, Snow GB. Lymph node staging in patients with clinically negative neck examinations by ultrasound and ultrasound-guided aspiration cytology. Am J Surg 1991; 162(4):362-366.
33. van den Brekel MW, Castelijins JA, Stel HV, et al. Occult metastatic neck disease: detection with US and US-guided fine needle aspiration cytology. Radiology 1991; 180(2):457-461.
34. Saini S, Stark DD, Hahn PF, Wittenberg J, Brady TJ, Ferrucci JT. Ferrite particles: a superparamagnetic MR contrast agent for the reticular endothelial system. Radiology 1987; 162:211-216.
35. Stark DD, Weissleder R, Elizondo CT, et al. Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. Radiology 1988; 168:297-301.
36. Weissleder R, Hahn PF, Stark DD, et al. Superparamagnetic iron oxide: enhanced detection of focal splenic tumors with MR imaging. Radiology 1988; 169:399-403.
37. Weissleder R. Elizondo CT, Josephson L, et al. Experimental lymph nodes metastases: enhanced detection with MR lymphography. Radiology 1989; 171:835-839.
38. Weissleder R, Elizondo CT, Wittenberg J, Lee AS, Josephson L. Brady T. Ultrasmall superparamagnetic iron oxide, an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology 1990; 175:494-498.
39. Tanoura T, Bernas M, Darkazani A, et al. MR lymphography with iron oxide compound AMI 227: studies in ferrets with filariasis. Am J Roentgenol 1992; 159:875-881.
40. Taupitz M, Wagner S, Hamm B, Binder A, Pfefferer D. Interstitial MR lymphography with Iron oxide particles: results in tumor-free and VX2 tumor-bearing rabbits. Am J Roentgenol 1993; 161:193-200.
41. Anzai Y, McLachlan S, Saxton R, Moris M, Lufkin RB. Dextran-coated superparamagnetic iron oxide: the first human use of a new MR contrast agent for assessing lymph nodes in the head and neck. Am J Neuroradiol 1994; 15:87-94.
42. Weissleder R, Elizondo CT, Wittenberg J, Rabito CA, Bengele HH, Josephson L. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology 1990; 175:489-493.
43. Mayo-Smith WW, Saini S, Slater G, Kaufman JA, Sharma P, Hahn PF. MR contrast material for vascular enhancement: value of superparamagnetic iron oxide. Am J Roentgenol 1996; 162:209-213.
44. Anzai Y, Prince MR, Chenevert TL, et al. MR angiography with an ultrasmall superparamagnetic iron oxide blood pool agent. JMRI 1997; 7:209-214.
45. ™) for imaging cervical lymph nodes: optimal dose, time of imaging, and pulse sequence (abstract). In: Proceedings of the annual meeting of ASHNR. Los Angeles, CA: American Society of Head and Neck Radiology, 1996.
46. Anzai Y, Blackwell K, Hirschowitz S, et al. Initial clinical experience with Dextran-coated superparamagnetic iron oxide for detection of lymph node metastases in patients with head and neck cancer. Radiology 1994; 192:709-715.
47. Lee AS, Weissleder R, Brady TJ, Wittenberg J. Lymph nodes: microstructural anatomy at MR imaging. Radiology 1991; 178: 519-522.
48. Haberkorn U, Strauss LG, Reisser C, et al. Glucose uptake, perfusion, and cell proliferation in head and neck tumors: relationship of positron emission tomography to flow cytometry. J Nucl Med 1991; 32:1548-1555.
49. Jabour BA, Choi Y, Hoh CK, et al. Extracranial head and neck: PET imaging with 2-[F-18] fluoro-2-deoxy-D-glucose and MR imaging correlation. Radiology 1993; 186:27-35.
50. Reisser C, Haberkorn U, Strauss LG. The relevance of positron emission tomography for the diagnosis and treatment of head and neck tumors. J Otolaryngol 1993; 22:231-238.
51. Rege S, Maass A, Chaiken L, et al. Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers. Cancer 1994; 73:3047-3058.
52. Greven KE, William DW, Keyes JW Jr, et al. Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation. Cancer 1994; 74:1355-1359.
53. Graven KM, Williams DW, Keyes JW, et al. Distinguishing tumor recurrence from irradiation sequelae with positron emission tomography in patients treated for laryngeal cancer. Int J Radiat Oncol Biol Phys 1994; 29:841-845.
54. Bailet JW, Sercarz JA, Abemayor E, Anzai Y, Lufkin R, Hoh CK. The use of positron emission tomography for early detection of recurrent head and neck squamous cell carcinoma in post-radiotherapy patients. Laryngoscope 1995; 105:135-139.
55. Lapela M, Grenman R, Kurki T, et al. Head and neck cancer: detection of recurrence with PET and 2-[F-18] fluoro-2-deoxy-D-glucose. Radiology 1995; 197:205-211.
56. Anzai Y, Carrol WR, Quint DJ, et al. Recurrent head and neck cancer after surgery or irradiation: Prospective comparison of 2-deoxy-2-[F-18] fluoro-D-glucose PET and MR imaging diagnoses. Radiology 1996; 200:135-141.
57. Chaiken L, Rege S, Hoh C, et al. Positron emission tomography with fluorodeoxyglucose to evaluate tumor response and control after radiation therapy. Int J Radiat Oncol Biol Phys 1993; 27: 455-464.
58. Berlangieri SU, Brizel DM, Scher RL, Schifter T, Hawk TC, Hamblen S. Pilot study of positron emission tomography in patients with advanced head and neck cancer receiving radiotherapy and chemotherapy. Head Neck 1994; 16:340-346.
59. Anzai Y, Hoh C, Abemayor E, et al. Clinical experience in FDG-PET imaging with PET-MR co-registration in the head and neck cancer (abstract). ASNR 1994.
60. Levin DN, Hu X, Tan KK, et al. The brain: integrated three dimensional display of MR and PET images. Radiology 1989; 172: 783-789.
61. Pelizzari CA, Chen GT, Spelbring DR, et al. Accurate three-dimensional registration of CT, PET, and/or MR images of the brain. J Comput Assist Tomogr 1989; 13(1):20-26.
62. Mukherji SK, Drane WE, Tart RP, Landau S, Mancuso AA. Comparison of thallium-201 and F-18 FDG-SPECT uptake in squamous cell carcinoma of the head and neck. Am J Neuroradiol 1994; 15(10):1837-1842.
63. Hassan IM, Sahweil A, Constantinides C, et al. Uptake and kinetics of Tc-99m hexzkis 2-methyoxy isobutyl isonitrile in benign and malignant lesions in the lung. Clin Nucl Med 1989; 14:333-340.
64. Camer B, Kitapel M, Unlu M, et al. Technetium-99m MIBI uptake in benign and malignant bone lesions: A comparative study with technetium-99m-MDP. J Nucl Med 1992; 33:319-324.
65. O'Tuama LA, Ted Trevis S, Larar JN, et al. Thallium-201 versus technetium-99m-MIBI SPECT in evaluation of childhood brain tumors: a within-subject comparison. J Nucl Med 1990; 31:1166-1167.
66. Crile GW. Excision of cancer of the head and neck with special reference to the plan of dissection based upon one hundred thirty-two operations. JAMA 1906; 47:1780.
67. Bocca E, Pignataro O. A conservation technique in radical neck dissection. Ann Otol Rhinol Laryngol 1967; 76:975-987.
68. Lindberg R. Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 1972; 29:1446-1449.
69. Marks JE, Breaux S, Smith PG, Thawley SE, Sessions DG. The need for elective irradiation of occult lymphatic metastases from cancers of the larynx and pyriform sinus. Head Neck Surg 1985; 8:3-8.